In line with the active role of the AAT in the onset of NASH and of the metabolic syndrome, the AAT CD4+RORγt++ correlated with liver histology as well as with some features of metabolic impairment, including weight gain. The gene discussed is SERPINA1; the disease is metabolic syndrome.